DiaMedica Therapeutics Announces $11.8M Private Placement, Will Issue A Total Of 4.72M Common Shares At A Purchase Price Of $2.50 Per Share
Portfolio Pulse from Benzinga Newsdesk
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) announced an $11.8 million private placement, issuing 4.72 million common shares at $2.50 per share. The transaction is expected to close around June 28, 2024, pending customary closing conditions.
June 26, 2024 | 12:17 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) has announced a private placement to raise $11.8 million by issuing 4.72 million common shares at $2.50 per share. The transaction is expected to close by June 28, 2024, subject to customary closing conditions.
The private placement will provide DiaMedica with significant capital to advance its clinical-stage biopharmaceutical projects. The issuance of new shares at a set price may dilute existing shareholders but also indicates investor confidence in the company's future prospects.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100